Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
As of close of business last night, AdaptHealth Corp’s stock clocked out at $8.89, down -3.58% from its previous closing price of $9.22. In other words, the price has decreased by -$3.58 from its previous closing price. On the day, 2.66 million shares were traded. AHCO stock price reached its highest trading level at $9.26 during the session, while it also had its lowest trading level at $8.871.
Ratios:
To gain a deeper understanding of AHCO’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 17.53 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 5.20. For the most recent quarter (mrq), Quick Ratio is recorded 0.82 and its Current Ratio is at 1.06. In the meantime, Its Debt-to-Equity ratio is 1.23 whereas as Long-Term Debt/Eq ratio is at 1.19.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for the company, Jefferies on January 08, 2024, Downgraded its rating to Hold and sets its target price to $8 from $14.50 previously.
On November 08, 2023, BofA Securities Downgraded its rating to Underperform which previously was Neutral and also lowered its target price recommendation from $9.50 to $6.50.
Stifel Downgraded its Buy to Hold on May 10, 2023, whereas the target price for the stock was revised from $18 to $11.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 22 ’25 when Williams David Solomon III sold 8,200 shares for $9.73 per share. The transaction valued at 79,786 led to the insider holds 50,045 shares of the business.
Rietkerk Shaw bought 32,500 shares of AHCO for $315,250 on Dec 19 ’24. On Dec 10 ’24, another insider, Clemens Jason A, who serves as the Chief Financial Officer of the company, sold 35,000 shares for $9.35 each. As a result, the insider received 327,250 and left with 420,719 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AHCO now has a Market Capitalization of 1202797184 and an Enterprise Value of 3063307776. As of this moment, AdaptHealth’s Price-to-Earnings (P/E) ratio for their current fiscal year is 16.62, and their Forward P/E ratio for the next fiscal year is 7.86. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.06. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.37 while its Price-to-Book (P/B) ratio in mrq is 0.76. Its current Enterprise Value per Revenue stands at 0.945 whereas that against EBITDA is 4.843.
Stock Price History:
The Beta on a monthly basis for AHCO is 1.63, which has changed by -0.19981998 over the last 52 weeks, in comparison to a change of 0.1653893 over the same period for the S&P500. Over the past 52 weeks, AHCO has reached a high of $11.70, while it has fallen to a 52-week low of $7.11. The 50-Day Moving Average of the stock is -4.43%, while the 200-Day Moving Average is calculated to be -5.71%.
Shares Statistics:
It appears that AHCO traded 1.26M shares on average per day over the past three months and 1166380 shares per day over the past ten days. A total of 135.22M shares are outstanding, with a floating share count of 90.42M. Insiders hold about 33.17% of the company’s shares, while institutions hold 78.21% stake in the company. Shares short for AHCO as of 1756425600 were 10439642 with a Short Ratio of 8.28, compared to 1753920000 on 10387889. Therefore, it implies a Short% of Shares Outstanding of 10439642 and a Short% of Float of 10.07.
Earnings Estimates
. The current rating of AdaptHealth Corp (AHCO) is the result of assessments by 6.0 analysts actively engaged in evaluating its market dynamics.The consensus estimate for the next quarter is $0.44, with high estimates of $0.5 and low estimates of $0.37.
Analysts are recommending an EPS of between $0.94 and $0.69 for the fiscal current year, implying an average EPS of $0.81. EPS for the following year is $1.14, with 6.0 analysts recommending between $1.23 and $0.97.
Revenue Estimates
In. The current quarter, 8 analysts expect revenue to total $799.62M. It ranges from a high estimate of $803.5M to a low estimate of $796.4M. As of. The current estimate, AdaptHealth Corp’s year-ago sales were $805.86MFor the next quarter, 8 analysts are estimating revenue of $847.88M. There is a high estimate of $863.1M for the next quarter, whereas the lowest estimate is $840.14M.
A total of 8 analysts have provided revenue estimates for AHCO’s current fiscal year. The highest revenue estimate was $3.24B, while the lowest revenue estimate was $3.22B, resulting in an average revenue estimate of $3.23B. In the same quarter a year ago, actual revenue was $3.26BBased on 8 analysts’ estimates, the company’s revenue will be $3.45B in the next fiscal year. The high estimate is $3.59B and the low estimate is $3.34B.
